These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

575 related articles for article (PubMed ID: 18924311)

  • 1. Breath analysis in non small cell lung cancer patients after surgical tumour resection.
    Poli D; Goldoni M; Caglieri A; Ceresa G; Acampa O; Carbognani P; Rusca M; Corradi M
    Acta Biomed; 2008; 79 Suppl 1():64-72. PubMed ID: 18924311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Volatile hydrocarbons in exhaled air: preliminary data on the characteristic profile associated with lung tumors].
    Corradi M; Poli D; Selis L; Carbognani P; Acampa O; Iavicoli S; Rusca M; Mutti A
    G Ital Med Lav Ergon; 2003; 25 Suppl(3):59-60. PubMed ID: 14979083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative breath analysis of volatile organic compounds of lung cancer patients.
    Song G; Qin T; Liu H; Xu GB; Pan YY; Xiong FX; Gu KS; Sun GP; Chen ZD
    Lung Cancer; 2010 Feb; 67(2):227-31. PubMed ID: 19409642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ion mobility spectrometry for the detection of volatile organic compounds in exhaled breath of patients with lung cancer: results of a pilot study.
    Westhoff M; Litterst P; Freitag L; Urfer W; Bader S; Baumbach JI
    Thorax; 2009 Sep; 64(9):744-8. PubMed ID: 19158121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An electronic nose in the discrimination of patients with non-small cell lung cancer and COPD.
    Dragonieri S; Annema JT; Schot R; van der Schee MP; Spanevello A; Carratú P; Resta O; Rabe KF; Sterk PJ
    Lung Cancer; 2009 May; 64(2):166-70. PubMed ID: 18834643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of aldehydes in exhaled breath of patients with lung cancer by means of on-fiber-derivatisation SPME-GC/MS.
    Poli D; Goldoni M; Corradi M; Acampa O; Carbognani P; Internullo E; Casalini A; Mutti A
    J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Oct; 878(27):2643-51. PubMed ID: 20149763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The analysis of volatile organic compounds biomarkers for lung cancer in exhaled breath, tissues and cell lines.
    Wang Y; Hu Y; Wang D; Yu K; Wang L; Zou Y; Zhao C; Zhang X; Wang P; Ying K
    Cancer Biomark; 2012; 11(4):129-37. PubMed ID: 23144150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exhaled volatile organic compounds in patients with non-small cell lung cancer: cross sectional and nested short-term follow-up study.
    Poli D; Carbognani P; Corradi M; Goldoni M; Acampa O; Balbi B; Bianchi L; Rusca M; Mutti A
    Respir Res; 2005 Jul; 6(1):71. PubMed ID: 16018807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A study of the volatile organic compounds exhaled by lung cancer cells in vitro for breath diagnosis.
    Chen X; Xu F; Wang Y; Pan Y; Lu D; Wang P; Ying K; Chen E; Zhang W
    Cancer; 2007 Aug; 110(4):835-44. PubMed ID: 17599760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Release of volatile organic compounds from the lung cancer cell line NCI-H2087 in vitro.
    Sponring A; Filipiak W; Mikoviny T; Ager C; Schubert J; Miekisch W; Amann A; Troppmair J
    Anticancer Res; 2009 Jan; 29(1):419-26. PubMed ID: 19331181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Organic metabolites in exhaled human breath--a multivariate approach for identification of biomarkers in lung disorders.
    Gaspar EM; Lucena AF; Duro da Costa J; Chaves das Neves H
    J Chromatogr A; 2009 Apr; 1216(14):2749-56. PubMed ID: 19036381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determination of volatile biomarkers for apoptosis and necrosis by solid-phase microextraction-gas chromatography/mass spectrometry: a pharmacometabolomic approach to cisplatin's cytotoxicity to human lung cancer cell lines.
    Pyo JS; Ju HK; Park JH; Kwon SW
    J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Dec; 876(2):170-4. PubMed ID: 19027370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determination of volatile organic compounds in exhaled breath of patients with lung cancer using solid phase microextraction and gas chromatography mass spectrometry.
    Ligor M; Ligor T; Bajtarevic A; Ager C; Pienz M; Klieber M; Denz H; Fiegl M; Hilbe W; Weiss W; Lukas P; Jamnig H; Hackl M; Buszewski B; Miekisch W; Schubert J; Amann A
    Clin Chem Lab Med; 2009; 47(5):550-60. PubMed ID: 19397483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endothelin-1 is increased in the breath condensate of patients with non-small-cell lung cancer.
    Carpagnano GE; Foschino-Barbaro MP; Resta O; Gramiccioni E; Carpagnano F
    Oncology; 2004; 66(3):180-4. PubMed ID: 15218307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experimental setup and analytical methods for the non-invasive determination of volatile organic compounds, formaldehyde and NOx in exhaled human breath.
    Riess U; Tegtbur U; Fauck C; Fuhrmann F; Markewitz D; Salthammer T
    Anal Chim Acta; 2010 Jun; 669(1-2):53-62. PubMed ID: 20510903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determination of volatile organic compounds as biomarkers of lung cancer by SPME-GC-TOF/MS and chemometrics.
    Rudnicka J; Kowalkowski T; Ligor T; Buszewski B
    J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Nov; 879(30):3360-6. PubMed ID: 21982505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TD-GC-MS analysis of volatile metabolites of human lung cancer and normal cells in vitro.
    Filipiak W; Sponring A; Filipiak A; Ager C; Schubert J; Miekisch W; Amann A; Troppmair J
    Cancer Epidemiol Biomarkers Prev; 2010 Jan; 19(1):182-95. PubMed ID: 20056637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Breath carbonyl compounds as biomarkers of lung cancer.
    Li M; Yang D; Brock G; Knipp RJ; Bousamra M; Nantz MH; Fu XA
    Lung Cancer; 2015 Oct; 90(1):92-7. PubMed ID: 26233567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breath analysis during one-lung ventilation in cancer patients.
    Kischkel S; Miekisch W; Fuchs P; Schubert JK
    Eur Respir J; 2012 Sep; 40(3):706-13. PubMed ID: 22267752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influences of mixed expiratory sampling parameters on exhaled volatile organic compound concentrations.
    Thekedar B; Oeh U; Szymczak W; Hoeschen C; Paretzke HG
    J Breath Res; 2011 Mar; 5(1):016001. PubMed ID: 21383425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.